Robert A. Roth

10.7k total citations
269 papers, 8.2k citations indexed

About

Robert A. Roth is a scholar working on Pharmacology, Molecular Biology and Immunology. According to data from OpenAlex, Robert A. Roth has authored 269 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pharmacology, 59 papers in Molecular Biology and 39 papers in Immunology. Recurrent topics in Robert A. Roth's work include Drug-Induced Hepatotoxicity and Protection (80 papers), Pharmacogenetics and Drug Metabolism (29 papers) and Drug Transport and Resistance Mechanisms (26 papers). Robert A. Roth is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (80 papers), Pharmacogenetics and Drug Metabolism (29 papers) and Drug Transport and Resistance Mechanisms (26 papers). Robert A. Roth collaborates with scholars based in United States, Czechia and France. Robert A. Roth's co-authors include Patricia E. Ganey, James A. Hewett, James P. Luyendyk, Jane F. Maddox, James G. Wagner, A. Eric Schultze, Patrick J. Shaw, Lawrence J. Dahm, Paul A. Jean and Yvonne Gold and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

Robert A. Roth

259 papers receiving 7.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert A. Roth United States 49 2.7k 1.9k 1.2k 1.1k 1.1k 269 8.2k
José A. G. Agúndez Spain 48 2.7k 1.0× 2.1k 1.1× 584 0.5× 287 0.3× 934 0.8× 295 8.4k
Gérard Siest France 61 2.5k 0.9× 4.1k 2.2× 604 0.5× 459 0.4× 1.5k 1.4× 519 14.5k
David A. Flockhart United States 63 5.6k 2.0× 3.9k 2.1× 390 0.3× 1.0k 0.9× 571 0.5× 255 15.3k
Achille P. Caputi Italy 60 945 0.3× 2.8k 1.5× 1.6k 1.4× 668 0.6× 944 0.9× 311 13.0k
Yu Li China 54 771 0.3× 4.2k 2.3× 700 0.6× 420 0.4× 2.2k 2.0× 330 10.3k
David J. Webb United Kingdom 53 744 0.3× 2.6k 1.4× 743 0.6× 840 0.7× 706 0.6× 187 11.1k
Jeffrey R. Idle United Kingdom 70 6.4k 2.3× 6.4k 3.5× 275 0.2× 555 0.5× 1.1k 0.9× 270 15.7k
Yin Lu China 45 529 0.2× 4.6k 2.5× 461 0.4× 967 0.9× 984 0.9× 226 8.5k
Richard M. Weinshilboum United States 77 5.0k 1.8× 8.7k 4.7× 980 0.8× 785 0.7× 973 0.9× 408 23.9k
Yu‐Jui Yvonne Wan United States 45 776 0.3× 3.1k 1.7× 702 0.6× 140 0.1× 1.4k 1.3× 184 6.3k

Countries citing papers authored by Robert A. Roth

Since Specialization
Citations

This map shows the geographic impact of Robert A. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Roth more than expected).

Fields of papers citing papers by Robert A. Roth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Roth. The network helps show where Robert A. Roth may publish in the future.

Co-authorship network of co-authors of Robert A. Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Roth. A scholar is included among the top collaborators of Robert A. Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Roth. Robert A. Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roth, Robert A.. (2016). Progress Toward Understanding Drug-Induced Liver Injury. 2(4). 183–184.
2.
Poulsen, Kyle L., Jesús Olivero‐Verbel, Kevin M. Beggs, Patricia E. Ganey, & Robert A. Roth. (2014). Trovafloxacin Enhances Lipopolysaccharide-Stimulated Production of Tumor Necrosis Factor-α by Macrophages: Role of the DNA Damage Response. Journal of Pharmacology and Experimental Therapeutics. 350(1). 164–170. 25 indexed citations
3.
Fullerton, Aaron, et al.. (2011). Natural Killer Cells Mediate Severe Liver Injury in a Murine Model of Halothane Hepatitis. Toxicological Sciences. 120(2). 507–518. 27 indexed citations
4.
Shaw, Patrick J., Patricia E. Ganey, & Robert A. Roth. (2009). Trovafloxacin Enhances the Inflammatory Response to a Gram-Negative or a Gram-Positive Bacterial Stimulus, Resulting in Neutrophil-Dependent Liver Injury in Mice. Journal of Pharmacology and Experimental Therapeutics. 330(1). 72–78. 31 indexed citations
5.
Rabin, L, Robert A. Roth, Peter Κ. Isquith, et al.. (2006). Self- and informant reports of executive function on the BRIEF-A in MCI and older adults with cognitive complaints. Archives of Clinical Neuropsychology. 21(7). 721–732. 130 indexed citations
6.
Yee, Steven B., Bryan L. Copple, Patricia E. Ganey, & Robert A. Roth. (2002). THE TEMPORAL RELATIONSHIP BETWEEN BACTERIAL LIPOPOLYSACCHARIDE AND MONOCROTALINE EXPOSURES INFLUENCES TOXICITY: SHIFT IN RESPONSE FROM HEPATOTOXICITY TO NITRIC OXIDE-DEPENDENT LETHALITY. Journal of Toxicology and Environmental Health. 65(14). 961–976. 5 indexed citations
7.
Ganey, Patricia E., et al.. (2001). Bacterial Lipopolysaccharide Enhances Aflatoxin B1 Hepatotoxicity in Rats by A Mechanism That Depends on Tumor Necrosis Factor α. Hepatology. 33(1). 66–73. 69 indexed citations
8.
Roth, Robert A.. (1997). Toxicology of the respiratory system. Pergamon eBooks. 10 indexed citations
9.
Pearson, Julia M., Alan Brown, A. Eric Schultze, Patricia E. Ganey, & Robert A. Roth. (1996). GADOLINIUM CHLORIDE TREATMENT ATTENUATES HEPATIC PLATELET ACCUMULATION AFTER LIPOPOLYSACCHARIDE ADMINISTRATION. Shock. 5(6). 408–415. 19 indexed citations
10.
Jean, Paul A. & Robert A. Roth. (1995). Naphthylisothiocyanate disposition in bile and its relationship to liver glutathione and toxicity. Biochemical Pharmacology. 50(9). 1469–1474. 46 indexed citations
11.
Roth, Robert A., Mustafa Akın, Ubeydullah Deligönül, & Morton J. Kern. (1991). Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters. Catheterization and Cardiovascular Diagnosis. 22(4). 290–294. 17 indexed citations
12.
Venditti, Ferdinand J., et al.. (1991). Renal Extracorporeal Shock Wave Lithotripsy Performed in Patient with Implantable Cardioverter Defibrillator. Pacing and Clinical Electrophysiology. 14(9). 1323–1325. 13 indexed citations
13.
Roth, Robert A.. (1989). The Teacher Education Program: An Endangered Species?.. Phi Delta Kappan. 71(4). 7 indexed citations
14.
Roth, Robert A., et al.. (1989). Dilation of benign ureteral strictures.. Radiology. 172(2). 437–441. 41 indexed citations
15.
Hewett, James A. & Robert A. Roth. (1988). Dieldrin activates rat neutrophils in vitro. Toxicology and Applied Pharmacology. 96(2). 269–278. 25 indexed citations
16.
Ganey, Patricia E. & Robert A. Roth. (1987). Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension. Biochemical Pharmacology. 36(20). 3535–3537. 5 indexed citations
17.
Roth, Robert A.. (1986). Emergency Certificates, Misassignment of Teachers, and Other "Dirty Little Secrets.".. Phi Delta Kappan. 67(10). 10 indexed citations
18.
Roth, Robert A.. (1981). Teacher Supply and Demand: A Model for Data Collection and Quotas for Student Teachers.. Phi Delta Kappan. 63(2). 1 indexed citations
19.
Roth, Robert A.. (1977). How Effective Are CBTE Programs. Phi Delta Kappan. 2 indexed citations
20.
Roth, Robert A., Jan Roth, & C. N. Gillis. (1977). Disposition of 14C-mescaline by rabbit lung.. Journal of Pharmacology and Experimental Therapeutics. 200(2). 394–401. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José A. G. Agúndez Breakdown of academic impact, for papers by Gérard Siest Breakdown of academic impact, for papers by David A. Flockhart Breakdown of academic impact, for papers by Achille P. Caputi Breakdown of academic impact, for papers by Yu Li Breakdown of academic impact, for papers by David J. Webb Breakdown of academic impact, for papers by Jeffrey R. Idle Breakdown of academic impact, for papers by Yin Lu Breakdown of academic impact, for papers by Richard M. Weinshilboum Breakdown of academic impact, for papers by Yu‐Jui Yvonne Wan
Rankless by CCL
2026